Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

Share Price is delayed by 15 minutes
Get Live Data
217.00    -2.00 (-0.91%)
Bid:
217.00
Ask:
217.50
Spread: 0.50 (0.23%)
Market Cap: £599.82m
MGAM Live PriceLast checked at - London Stock Exchange

Intraday Morgan Advanced Materials Share Chart

Q1 Trading Update

23 Apr 2018 07:00

RNS Number : 7079L
Morgan Advanced Materials PLC
23 April 2018
 

 

 

Press Release

 

Morgan Advanced Materials plc

23 April 2018

Q1 trading update

 

Sales for the first three months to March 2018 were 6.5% higher for the Group, on an organic constant currency basis, compared to the first quarter of last year.

 

By business, the organic constant currency trends for the first quarter compared to prior year are as follows. Sales for the Thermal Products division were 6.2% higher than the prior year, with growth in Asia and Europe. Within the Carbon and Technical Ceramics division, sales were 9.0% higher than last year, with above trend growth in Seals & Bearings driven by ceramic armour sales, good growth in Electrical Carbon, and modest growth in Technical Ceramics. The Composites and Defence Systems business has continued its recent declining trend.

 

Morgan Advanced Materials plc also announces that the Board has decided to exit the Composite and Defence Systems business. This exit will take the form of the potential divestment of certain product lines, should a suitable acquirer be found, together with the closure of the remainder of the business lines. Discussions with potential acquirers of certain product lines are at a very early stage, and there can be no certainty that any divestments will be made.

 

The provisional cash exit costs from closing the Composites and Defence Systems business are anticipated to be around £6 million, which may be partially offset by any proceeds from the divestment of certain product lines and the sale of certain fixed assets of the business.

 

Looking forward to the balance of the year for the Group as a whole, the growth rate achieved in the first quarter is higher than we anticipate for the full year, reflecting a relatively weaker comparator period in the first quarter of the prior year. We currently anticipate that full year headline operating profit margins will be slightly ahead of the prior year, with the benefits of pricing, efficiency savings and volume leverage being partially offset by the planned reinvestment in research and development and sales resources, as well as the dilutive impact of the divestments completed in 2017.

 

This announcement contains inside information, the person responsible for releasing this announcement on behalf of the company is Peter Turner.

For further enquiries:

 

Pete Raby

Morgan Advanced Materials plc

01753 837 000

Peter Turner

 

Alison Kay

 

Brunswick

 

0207 404 5959

 

Notes:

The next scheduled update is the Group's half-year results presentation on 26 July 2018.

Legal Entity Identifier: I4K14LL95N2PHDL7EG85

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTZXLBLVZFXBBD
Date   Source Headline
30th Nov 20113:26 pmRNSScrip Dividend Price
30th Nov 20111:16 pmRNSHolding(s) in Company
29th Nov 20114:06 pmRNSHolding(s) in Company
25th Nov 20119:41 amRNSDirector/PDMR Shareholding
14th Nov 20117:00 amRNSInterim Management Statement
18th Oct 20119:29 amRNSHolding(s) in Company
5th Oct 20115:50 pmRNSHolding(s) in Company
4th Oct 20119:57 amRNSDirector/PDMR Shareholding
12th Sep 201112:16 pmRNSDirector/PDMR Shareholding
31st Aug 20114:08 pmRNSHolding(s) in Company
24th Aug 201112:33 pmRNSDirector/PDMR Shareholding
11th Aug 20119:45 amRNSHalf Yearly Report
1st Aug 20119:35 amRNSTotal Voting Rights
20th Jul 20113:10 pmRNSDirector/PDMR Shareholding
13th Jul 20117:00 amRNSTrading Statement
8th Jul 20115:40 pmRNSDirector/PDMR Shareholding
8th Jul 20115:27 pmRNSTotal Voting Rights
1st Jul 201111:06 amRNSIssue of Equity
15th Jun 201112:03 pmRNSBlocklisting Interim Review
25th May 20119:57 amRNSScrip Dividend Price
11th May 20113:32 pmRNSResult of AGM
10th May 20117:00 amRNSInterim Management Statement
18th Apr 20112:59 pmRNSAnnual Information Update
8th Apr 20113:30 pmRNSDirector/PDMR Shareholding
8th Apr 201112:23 pmRNSHolding(s) in Company
8th Apr 201112:21 pmRNSDirector/PDMR Shareholding
6th Apr 20115:00 pmRNSDirector/PDMR Shareholding
31st Mar 20117:00 amRNSAnnual Financial Report
31st Mar 20117:00 amRNSCapital Markets Presentation
25th Mar 20114:01 pmRNSHolding(s) in Company
25th Mar 20113:57 pmRNSDirector/PDMR Shareholding
24th Mar 20115:10 pmRNSDirector/PDMR Shareholding
24th Mar 20113:03 pmRNSDirector/PDMR Shareholding
15th Mar 20116:00 pmRNSHolding(s) in Company
15th Mar 20115:58 pmRNSHolding(s) in Company
4th Mar 20115:09 pmRNSDirector/PDMR Shareholding
28th Feb 20115:27 pmRNSTotal Voting Rights
16th Feb 20117:00 amRNSFull Year Results
31st Jan 201110:26 amRNSTotal Voting Rights
28th Jan 20111:33 pmRNSAppointment as a Non-Executive Director
17th Jan 20113:20 pmRNSHolding(s) in Company
17th Jan 20113:20 pmRNSDirector/PDMR Shareholding
14th Jan 20117:00 amRNSAcquisition
13th Jan 201110:15 amRNSAppointment of Tim Stevenson to Johnson Matthey
12th Jan 20111:21 pmRNSHolding(s) in Company
12th Jan 20119:34 amRNSDirector/PDMR Shareholding
12th Jan 20119:30 amRNSTotal Voting Rights
5th Jan 201110:40 amRNSIssue of Shares under Scrip Dividend Scheme
15th Dec 20104:04 pmRNSBlocklisting Interim Review
8th Dec 20104:07 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.